Scott Stanford - 23 Sep 2021 Form 3 Insider Report for Cue Health Inc.

Role
Director, 10%+ Owner
Signature
/s/ Erica Palsis, Attorney-in-Fact of Scott Stanford
Issuer symbol
N/A
Transactions as of
23 Sep 2021
Net transactions value
$0
Form type
3
Filing time
23 Sep 2021, 21:06:23 UTC
Previous filing
02 Jul 2021
Next filing
30 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HLTH Common Stock 129,354 23 Sep 2021 See Footnote F1
holding HLTH Common Stock 194,031 23 Sep 2021 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HLTH Series A Preferred Stock 23 Sep 2021 Common Stock 5,450,898 See Footnote F1, F3
holding HLTH Series B Preferred Stock 23 Sep 2021 Common Stock 3,076,224 See Footnote F1, F4
holding HLTH Series B Preferred Stock 23 Sep 2021 Common Stock 3,834,088 See Footnote F2, F4
holding HLTH Series C-1 Preferred Stock 23 Sep 2021 Common Stock 1,092,329 See Footnote F1, F5
holding HLTH Series C-1 Preferred Stock 23 Sep 2021 Common Stock 1,092,329 See Footnote F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by Sherpa Ventures Fund, LP ("ACME I"). Sherpa Ventures Fund GP, LLC ("ACME GP I") is the general partner of ACME I. Scott Stanford is the sole managing member of each of ACME GP I and ACME GP II (as defined below) and may be deemed to have voting and investment power with respect to the shares held by ACME I and ACME II (as defined below) and as a result may be deemed to have beneficial ownership of such shares. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of his or its respective pecuniary interest therein.
F2 The shares are held directly by Sherpa Ventures Fund II, LP ("ACME II"). Sherpa Ventures Fund II GP, LLC ("ACME GP II") is the general partner of ACME II. Scott Stanford is the sole managing member of each of ACME GP I and ACME GP II and may be deemed to have voting and investment power with respect to the shares held by ACME I and ACME II and as a result may be deemed to have beneficial ownership of such shares. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of his or its respective pecuniary interest therein.
F3 The Series A Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F4 The Series B Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F5 The Series C-1 Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.

Remarks:

Exhibit Index: 24.1 Power of Attorney